alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                          9,879
<SECURITIES>                                        0
<RECEIVABLES>                                  27,715 <F1>
<ALLOWANCES>                                     (980)
<INVENTORY>                                         0
<CURRENT-ASSETS>                               48,391
<PP&E>                                          5,022 <F2>
<DEPRECIATION>                                      0
<TOTAL-ASSETS>                                 60,907
<CURRENT-LIABILITIES>                          18,577
<BONDS>                                            45 <F3>
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                          184
<OTHER-SE>                                     42,285
<TOTAL-LIABILITY-AND-EQUITY>                   60,907
<SALES>                                             0
<TOTAL-REVENUES>                               78,240
<CGS>                                               0
<TOTAL-COSTS>                                  65,564
<OTHER-EXPENSES>                               10,598
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                                438 <F4>
<INCOME-PRETAX>                                 2,516
<INCOME-TAX>                                    1,069
<INCOME-CONTINUING>                             1,447
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                    1,447
<EPS-BASIC>                                      0.08
<EPS-DILUTED>                                    0.08


<FN>
<F1>
Shown net of allowance for uncollectible accounts on face of Consolidated
Balance Sheet.

<F2>
Shown in this Financial Data Schedule net of related accumulated depreciation
for consistency with Consolidated Balance Sheet.

<F3>
Represents the long-term portion of capital lease obligations.

<F4>
Represents interest and other income, net of the Company.
</FN>








</TABLE>
Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report of United Energy Corp. (the Company) on
Form 10-KSB for the year ending March 31, 2006 as filed with the Securities and
Exchange Commission on the date hereof (the Report), the undersigned, in the
capacities and on the date indicated below, hereby certifies, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

|                       |                                   |                     
|---------------------- | --------------------------------- | --------------------
|Dated: June
  28, 2007 | By:                               | /s/ Brian
  King    
|                       |                                   |                     
|                       | Brian King                       
|                       | Chief
  Executive Officer        
|                       |                                   |                     
|Dated: June
  28, 2007 | By:                               | /s/ James
  McKeever
|                       |                                   |                     
|                       | James
  McKeever                 
|                       | Interim
  Chief Financial Officer

---
111TH CONGRESS 

2D SESSION H. R. 5877 

AN ACT 

To designate the facility of the United States Postal Service 

located at 655 Centre Street in Jamaica Plain, Massachusetts, as the ‘‘Lance Corporal Alexander Scott 

Arredondo, United States Marine Corps Post Office 

Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 5877 EH

1 SECTION 1. LANCE CORPORAL ALEXANDER SCOTT 

2 ARREDONDO, UNITED STATES MARINE 

3 CORPS POST OFFICE BUILDING. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 655 Centre Street in Jamaica 

6 Plain, Massachusetts, shall be known and designated as 

7 the ‘‘Lance Corporal Alexander Scott Arredondo, United 

8 States Marine Corps Post Office Building’’. 

9 (b) REFERENCES.—Any reference in a law, map, reg10 ulation, document, paper, or other record of the United 

11 States to the facility referred to in subsection (a) shall 

12 be deemed to be a reference to the ‘‘Lance Corporal Alex13 ander Scott Arredondo, United States Marine Corps Post 

14 Office Building’’. 

Passed the House of Representatives November 29, 

2010. 

Attest: 

Clerk. 

111TH CONGRESS 

2D SESSION H. R. 5877 

AN ACT 

To designate the facility of the United States PostMarine Corps Post Office Building’’. poral Alexander Scott Arredondo, United States maica Plain, Massachusetts, as the ‘‘Lance Cor- al Service located at 655 Centre Street in Ja-
UN PUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 17
- 1910

In re: SUNDARI K. PRASAD , Petitioner.

On Petition For Writ of Mandamus . ( 3:17

- cv - 00042

- JAG )

Submitted : November 21, 2017 Decided: November 27, 2017

Before WYNN and THACKER , Circuit Judges , and HAMILTON, Senior Circuit Judge

.

Petition denied by un published per curiam opinion

.
Sundari K. Prasad, Petitioner Pro Se.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Sundari K. Prasad petitions for a writ of mandamus seeking an order directing (1) the recusal of two judges of the United States District Court for the Eastern District of Virginia; (2) that Prasad be appointed counsel in all of her pending district court cases and transferred to another correctional institution ; and ( 3 ) the reversal of all prior adverse rulings in her civil actions. Mandamus relief is a drastic remedy and should be used only in extraordinary circumstances. Kerr v. U.S. Dist. Court, 426 U .S. 394, 402 (1976); United States v. Moussaoui , 333 F.3d 509, 516

- 17 (4th Cir. 2003). We have reviewed Prasad’s petition and conclude that Prasad is not entitled to mandamus relief. First, Prasad has failed to establish the extra

- judicial bias necessar y for this court to direct the recusal of the identified district court judges from participation in
he r pending civil actions

. See In re Beard , 811 F.2d 818, 826

- 27 (4th Cir. 1987) ; see also United States v. Owens , 902 F.2d 1154, 1156 (4th Cir. 1990) ( “ P arties cannot be allowed to create the basis for recusal by their own deliberate actions. To hold otherwise would encourage inappropriate ‘judge shopping.’” ). Next, Prasad has not demonstrated her clear entitlement to having counsel appointed in all of h er pending civil cases or a transfer to another correctional institution , and mandamus relief is available only when the petitioner has a clear right to the relief sought. In re First Fed. Sav. & Loan Ass’n, 860 F.2d 135, 138 (4th Cir. 1988). Finally, because m andamus may not be used as a substitute for appeal , In re Lockheed Martin Corp. , 503 F.3d 351, 353 (4th Cir. 2007) , we deny Prasad’s request for reversal of all adverse rulings in her civil cases.3 For these reasons, we deny the petition for wri t of mandamus. We further deny Prasad’s motions to consolidate this petition with another pending appeal and to change the style of this case to that of a petition for a writ of prohibition. We dispense with oral argument because the facts and legal cont entions are adequately presented in the materials before this court and argument would not aid the decisional process.
PETITION DENIED
exv10w53






Exhibit 10.53




Non-Employee Director Compensation Summary



Alseres Pharmaceuticals, Inc.’s (the “Company’s”) non-employee directors at December 31, 2009
consisted of: William L.S. Guinness; Robert S. Langer, Jr.; Michael J. Mullen; John T. Preston;
Gary E. Frashier; and Henry Brem.



For the year ended December 31, 2009, the Company’s non-employee director compensation was earned
as follows, however, the Company has only paid non-employee director compensation through June 30,
2008 and at December 31, 2009 owed its independent directors a total of $455,000 in compensation:




	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Per Board and	 	 
	 	 	 	 	 	 	Committee	 	Annual Fee Per
	 	 	2009 Annual	 	 	 	 
	 	 	Retainer	 	Meeting Fees (1)	 	Committee Chaired
	William L.S. Guinness
	 	$	25,000	 	 	$	2,500	 	 	 	—	 
	Robert S. Langer, Jr.
	 	$	25,000	 	 	$	2,500	 	 	$	10,000	 
	Michael J. Mullen
	 	$	25,000	 	 	$	2,500	 	 	$	20,000	 
	John T. Preston
	 	$	25,000	 	 	$	2,500	 	 	$	20,000	 
	Gary E. Frashier
	 	$	25,000	 	 	$	2,500	 	 	$	10,000	 
	Henry Brem
	 	$	25,000	 	 	$	2,500	 	 	 	—	 








 




			
	(1)	 	Board and committee fees are paid on a per meeting basis at $2,500 per meeting.




All non-employee directors are reimbursed for ordinary and reasonable expenses of attending any
board or committee meetings.



Each new non-employee director is automatically granted an option to purchase 25,000 shares of the
Company’s common stock (“New Director Options”) upon initial election or appointment (the
“Automatic Grant Date”). The exercise price of any New Director Options granted shall equal the
fair market value of shares of the Company’s common stock subject thereto on the Automatic Grant
Date. New Director Options immediately vest as to 1/3 of the shares subject to such New Director
Options with the remaining 2/3 of the shares subject to such New Director Option vesting in equal
monthly installments over two years (“New Director Option Vesting”).



Each non-employee director is automatically granted an option to purchase 25,000 shares of the
Company’s common stock each year (“Annual Director Options”). The Annual Director Options are
granted in the fourth quarter of each calendar year (the “Annual Grant Date”). The exercise price
of any Annual Director Options granted shall equal the fair market value of shares of the Company’s
common stock subject thereto on the Annual Grant Date. Annual Director Options vest in equal
monthly installments over two years (“Annual Director Option Vesting”). Newly elected non-employee
directors are eligible to receive the Annual Director Options in the fourth quarter of the second
calendar year of service.
<PAGE>
                                                                    EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies in his capacity as an officer of
American Physicians Capital, Inc. (the "Company"), for purposes of 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to the best of his knowledge:

         (1) The Annual Report of the Company on Form 10-K for the period ended
December 31 31, 2003 fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and

         (2) The information contained in such Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


Date:  March 12, 2004


/s/ R. Kevin Clinton
-----------------------------------
R. Kevin Clinton
President and Chief Executive Officer


 /s/ Frank H. Freund
-----------------------------------
Frank H. Freund
Senior Executive Vice President, Treasurer
And Chief Financial Officer
#### Tallman *et al. v.*Tallman *et al.*

Appeal from Montgomery City Court, in Equity.

Heard before the Hon. A. D. Sayre.

J. Winter Thorington, for appellants.

*649William S. Thorington, for appellees.

Opinion by

Haralson, J.

Tlie bill in this case was filed by the appellees against the appellants. In February, 1892, Charles 1). Tallman, by will bequeathed to Bichard P. Tallman a considerable sum of money (about $2,000) in trust for the children of said Bichar cl P. Tallman, who are the complainants, to be managed by him at his discretion for their benefit, and without any bond being required of said Bichard P. Tallman. The said Bichard P. Tallman, after receiving the money, became enfeebled in health, and apprehending that in the event of his death his wife would be unable to give the bond that would be necessary to enable her to assume the trust, and that the trust estate would therefore pass into the hands of strangers, he concluded to invest, and did invest, the remaining portion of the trust funds in the house and lot described in the bill, taking the deed in the wife’s name. In this there was no purpose to benefit himself but the *cestuis que trust.*After that the Avife became insane and remains hopelessly so.

The bill is filed by the *cestuis que trust*to vacate the conveyance to the Avife and to invest the title in the trustee for the benefit of the *cestuis que trust*subject to the original trust. The court beloAV granted the relief prayed and from that decree the appeal is taken.

The decree is affirmed.
Court of Appeals of the State of Georgia Clerk's Office, Atlanta, September 26, 2014. I certify that the above is a true extract from the minutes of the Court of Appeals of Georgia. Witness my signature and the seal of said court hereto affixed the day and year last above written. , Clerk. 

# Court of Appeals of the State of Georgia
ATLANTA, September 26, 2014 The Court of Appeals hereby passes the following order A15D0024. MACEDONIA BAPTIST CHURCH OF ATLANTA v. LIB PROPERTIES, LTD et al..
Upon consideration of the Application for Discretionary Appeal, it is ordered that it be hereby DENIED.
LC NUMBERS: 07CV131798
Exhibit 13.2

CHINA MOBILE LIMITED

Certification

Pursuant
to 18 U.S.C. § 1350, the undersigned, DONG Xin, Executive Director, Vice President and Chief Financial Officer of China Mobile Limited (the Company), hereby certifies, to his knowledge, that the Companys annual report on Form 20-F for the year ended December 31, 2016 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and that the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
April 27, 2017



/s/ DONG XinName:

DONG XinTitle:

Executive Director, Vice President and Chief Financial Officer


The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being
filed as part of the Report or as a separate disclosure document.
#### BUSTIN, Respondent, v. DAVIS, Appellant.

(Common Pleas of New York City and County, General Term.

April 25, 1894.)

Appeal from district court.

Action by John Bustin against William Davis.

Argued before BOOKSTAVER and BISCHOFF, JJ.

A. Kahn, for appellant.

D. Herschfield, for respondent.

No opinion. Judgment affirmed, with costs.
xml version="1.0" encoding="UTF-8"?


C\_2021392EN.01000501.xml


| | | | |
| --- | --- | --- | --- |
| 28.9.2021 | EN | Official Journal of the European Union | C 392/5 |

---

Prior notification of a concentration

(Case M.10247 — CVC/ Cooper)

(Text with EEA relevance)

(2021/C 392/04)

1.

On 17 September 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2021392EN.01000501-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | CVC Capital Partners SICAV-FIS S.A. (‘CVC’, Luxembourg), |

| | |
| --- | --- |
| — | Cooper Consumer Health S.A.S. and its subsidiaries (‘Cooper’, France). |

CVC acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Cooper.

The concentration is accomplished by way of purchase of securities.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | CVC manages investment funds and platforms, |

| | |
| --- | --- |
| — | Cooper produces and markets various self-care products used for diagnosis, prevention, treatment and enhancements. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

Case M.10247 CVC/ Cooper

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2021392EN.01000501-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

---
[Federal Register Volume 65, Number 76 (Wednesday, April 19, 2000)]
[Notices]
[Page 21001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9718]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel, Mid Career Investigator Award in Patient-Oriented Research.
    Date: April 26, 2000.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 7201 Wisconsin Avenue, Gateway Building, Rm 2C212, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ramesh Vemuri, Office of Scientific Review, 
National Institute on Aging, Bethesda Gateway Building, Suite 2C212, 
Bethesda, MD 20892, 301-496-9666.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel.
    Date: April 25, 2000.
    Time: 10:15 a.m. to 11:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: 7201 Wisconsin Avenue, Gateway Building, Rm 2C212, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jeffrey M. Chernak, Bethesda Gateway Building, 
7201 Wisconsin Avenue, Rm 2C212, Bethesda, MD 20892, 301-496-9666.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel.
    Date: April 26, 2000.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 7201 Wisconsin Avenue, Gateway Building, Rm 2C212, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Mary Nekola, Chief, Office of Scientific Review, 
National Institute on Aging, Bethesda Gateway Building, Suite 2C212, 
Bethesda, MD 20892, 301-496-9666.


(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)
    Dated: April 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-9718 Filed 4-18-00; 8:45 am]
BILLING CODE 4140-01-M
# M-274, I-9 Central Guidance Revised to Increase Visibility of Certain Form I-9 Documents

You asked, we answered: In response to public inquiries about the Form I-9 Lists of Acceptable Documents, especially List C # 7 documents, USCIS is clarifying its guidance. Sample images of List C # 7 documents as well as information on acceptable documents are now easier to find on I-9 Central and in the M-274, Handbook for Employers. Please see Form I-9 Acceptable Documents, and the revised subsections of the Handbook for Employers, M-274:
                - Sections 13.1
                - Section 13.2
                - Section 13.3

03/25/2024

0 / 2000To protect your privacy, please do not include any personal information in your feedback. Review our Privacy Policy.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM YEAR
ENDED DECEMBER 31, 1998 FINANCIAL STATEMENTS OF U.S. AUTOMOBILE ACCEPTANCE SNP
III, INC. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH DECEMBER 31,
1998 10-K.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              20,622,722
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               (5,740,961)
<SALES>                                              0
<TOTAL-REVENUES>                             2,644,886
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (5,309,235)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (5,309,235)
<EPS-PRIMARY>                               (5,309.24)
<EPS-DILUTED>                               (5,309.24)
        

</TABLE>